Literature DB >> 10439966

Genetic and clinical analysis in 10 Spanish patients with multiple endocrine neoplasia type 1.

A Cebrián1, J L Herrera-Pombo, J J Díez, O Sánchez-Vilar, J I Lara, C Vázquez, A Picó, A Osorio, B Martínez-Delgado, J Benítez, M Robledo.   

Abstract

Multiple endocrine neoplasia type 1 (MEN 1) is characterised by the combination of tumours of the parathyroid, endocrine pancreas and anterior pituitary glands. In 1988 the MEN 1 gene was mapped to chromosome 11q13 and it was cloned in 1997. This gene contains 10 exons and extends across 9 Kb of genomic DNA; it encodes for a product of 610 amino acid named menin whose function is unknown. We have studied 10 unrelated MEN 1 kindreds by a complete sequencing analysis of the entire gene; mutations were identified in nine of them: five deletions, one insertion, two nonsense mutation and a complex alteration consisting of a deletion and an insertion that can be explained by a hairpin loop model. Two of the mutations have been previously described; the other seven were novel, and they were scattered throughout the coding sequence of the gene. As in previous series, no correlation was found between phenotype and genotype.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10439966     DOI: 10.1038/sj.ejhg.5200336

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  1 in total

1.  Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database.

Authors:  Francesca Marini; Francesca Giusti; Caterina Fossi; Federica Cioppi; Luisella Cianferotti; Laura Masi; Francesca Boaretto; Stefania Zovato; Filomena Cetani; Annamaria Colao; Maria Vittoria Davì; Antongiulio Faggiano; Giuseppe Fanciulli; Piero Ferolla; Diego Ferone; Paola Loli; Franco Mantero; Claudio Marcocci; Giuseppe Opocher; Paolo Beck-Peccoz; Luca Persani; Alfredo Scillitani; Fabiana Guizzardi; Anna Spada; Paola Tomassetti; Francesco Tonelli; Maria Luisa Brandi
Journal:  Endocrine       Date:  2018-03-01       Impact factor: 3.633

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.